SLIDESHOW: Dividend Growth Stocks: 25 Aristocrats
By Dividend Channel Staff, updated Wed, May 31, 5:23 AM
This Slide: #1 of 25 |
#25. AbbVie Inc (NYSE:ABBV) — 4.30% Yield
AbbVie is a research-based biopharmaceutical company. Co. operates as a single business segment dedicated to the research and development, manufacturing, commercialization and sale of medicines and therapies. Co.'s products include: immunology products such as Humira, Skyrizi, and Rinvoq; oncology products such as Imbruvica and Venclexta/Venclyxto; aesthetics products such as Botox Cosmetic and The Juvederm Collection of Fillers; neuroscience products such as Botox Therapeutic, Vraylar, and Ubrelvy; eyecare products such as Lumigan/Ganfort, Alphagan/Combigan, and Restasis; women's health products such as Lo Loestrin and Orilissa/Oriahnn; and other key products such as Creon and Synthroid. View ABBV's Dividend History»
ETFs holding ABBV
![]()
|
Open the Dividend Channel ABBV Page (in a new window) »

![]() ![]() |

![]() ABBV Next Dividend Date » (Projection based upon history) ABBV Dividend Growth Rate » Quotes delayed 20 minutes ![]() |
![]() Buy (2.97 out of 4) 28th percentile
(ranked lower than approx. 72% of all stocks covered)
Analysts' Target Price: ABBV Forecast Based on data provided by Zacks Investment Research via Quandl.com ![]() |

![]() |